Biotech companies could add growth to your portfolio -- and in some cases, at a bargain price. It’s a great idea to select tomorrow's potential winners and hold on as their stories unfold. If you're ...

Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

A prominent cancer scientist is uprooting his Harvard University lab of two decades and moving it to Texas. A laid-off expert on aging abandoned academia for a more secure municipal research job in ...

Shares of Arcellx, a mid-cap drug developer, headed for their best day on record Monday after Gilead Sciences agreed to buy it in a deal worth $7.8 billion.

New Delhi: The Supreme Court on Thursday came down heavily on Noida-based drug maker Marion Biotech, whose cough syrups were linked to the deaths of 18 children in Uzbekistan in 2022, remarking that ...